The Recall Desk
ModerateFDA (Devices)·Z-0383-2019·Announced 2018-11-14

Qiagen EZ1 Advanced XL Recalled for Potential Heater Malfunction

Qiagen is recalling 298 EZ1 Advanced XL instruments due to a power board defect that may cause heater malfunctions and compromise nucleic acid extractions.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text describes a functional defect that compromises test results and causes delays rather than a direct risk of physical injury or death to the user. This aligns with a moderate severity rating for a professional medical device where the primary hazard is data integrity and workflow disruption.

Plain-English summary

Qiagen Sciences LLC is recalling 298 units of the EZ1 Advanced XL instrument (Model Number: 9001492, GTIN: 04053228010760). The recall is due to an issue with the power branching printed circuit board (PCB) that has the potential to trigger a heater malfunction.

If this failure occurs, nucleic acid extractions could be compromised, requiring the extractions to be repeated. This may cause a delay in obtaining results from downstream applications. The affected products were distributed worldwide, including in the United States and numerous foreign countries.

The instrument is intended for use by professional users, such as technicians and physicians trained in molecular biological techniques. Users should check their instrument's serial number against the list of affected codes provided in the official recall notice to determine if their unit is included in this recall.

The recalled product

Product
EZ1 Advanced XL, Model Number: 9001492, GTIN: 04053228010760 Product Usage: The EZ1 Advanced XL is designed to perform automated isolation and purification of nucleic acids. It is intended to be used only in combination with QIAGEN kits indicated for use with the EZ1 Advanced
Affected units
298

Distribution

Distributed nationwide across the United States.

The notice also names 21 states specifically: